Research Article

Anti-proliferative effect of Cistus laurifolius on human cervical adenocarcinoma (Hep2C), human muscle rhabdomyosarcoma (RD), mouse fibrosarcoma (Wehi 164) cell line

Volume: 14 Number: 2 August 15, 2021
EN TR

Anti-proliferative effect of Cistus laurifolius on human cervical adenocarcinoma (Hep2C), human muscle rhabdomyosarcoma (RD), mouse fibrosarcoma (Wehi 164) cell line

Abstract

In the current study; it was tried to determine antiproliferative activity of extract obtained from Cistus laurifolius leaves on different cancer cell type such as human cervical adenocarcinoma cells (Hep2C), human muscle rhabdomyosarcoma cells (RD), mouse fibrosarcoma cells (Wehi 164) by MTT Assay. The results indicated that Cistus laurifolius inhibited, in a dose-dependent manner, the proliferation of Hep2C, RD, Wehi 164 cells. Maximum anti-proliferatif effects were observed in 1000 µg/ml, 500 µg/ml, 250µg/ml concentrations of extract. These findings suggest that Cistus laurifolius extract could reduce proliferatif effect of cancer cell lines. Their use as potential anticancer agent needs further studies.

Keywords

References

  1. [1] Quadri, M.F.A., Saleh, S.M., Rashad Alsanosy, R., Abdelwahab, S.I., Tobaigy, F. M., Mohamed Maryoud, M., Al-Hebshi, N. (2014). Effectiveness of an Intervention Program on Knowledge of Oral Cancer among the Youth of Jazan, Saudi Arabia. Asian Pacific Journal of Cancer Prevention, 15.
  2. [2] World Cancer Report: Cancer Research for Cancer Prevention. (2020). Edited by: Wild, C.P., Weiderpass, E., Stewart, B.W. ISBN 13 978-92-832-0448-0.
  3. [3] Shin, S.A., Moon, S.Y., Kim, W.Y., Paek, S.M., Park, H.H., Lee, C.S. (2018). Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites. International Journal of Molecular Science. 19, 2651.
  4. [4] Li, W. (2002). Botanical Drugs: The Next New New Thing? Available at: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965577 (accessed March 20, 2021).
  5. [5] Robinson, M.M, Zhang, X. (2011). The TheWorld Medicines Situation 2011. Geneva:World Health Organization.
  6. [6] Meng, F., Cheng, R., Deng, C., Zhong, Z., Intracellular drug release nanosystems. Materialtoday, 15-10.
  7. [7] Fridlender, M., Kapulnik, Y. and Koltai, H. (2015) Plant derived substances with anti-cancer activity: from folklore to practice. Front. Plant Sci, 6,799.
  8. [8] Dai, S.X., Li, W.X., Han, F.F., Guo, Y.C., Zheng, J.J., Liu, J.Q., Wang, Q., Gao, Y.D., Li, G.H., Huang, J. F. (2016). In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database. Scientific Reports, 6, 25462.

Details

Primary Language

English

Subjects

Conservation and Biodiversity

Journal Section

Research Article

Publication Date

August 15, 2021

Submission Date

April 5, 2021

Acceptance Date

July 17, 2021

Published in Issue

Year 2021 Volume: 14 Number: 2

APA
Soydam Aydın, S., & Yücel, E. (2021). Anti-proliferative effect of Cistus laurifolius on human cervical adenocarcinoma (Hep2C), human muscle rhabdomyosarcoma (RD), mouse fibrosarcoma (Wehi 164) cell line. Biological Diversity and Conservation, 14(2), 236-241. https://doi.org/10.46309/biodicon.2021.908458
AMA
1.Soydam Aydın S, Yücel E. Anti-proliferative effect of Cistus laurifolius on human cervical adenocarcinoma (Hep2C), human muscle rhabdomyosarcoma (RD), mouse fibrosarcoma (Wehi 164) cell line. BioDiCon. 2021;14(2):236-241. doi:10.46309/biodicon.2021.908458
Chicago
Soydam Aydın, Semra, and Ersin Yücel. 2021. “Anti-Proliferative Effect of Cistus Laurifolius on Human Cervical Adenocarcinoma (Hep2C), Human Muscle Rhabdomyosarcoma (RD), Mouse Fibrosarcoma (Wehi 164) Cell Line”. Biological Diversity and Conservation 14 (2): 236-41. https://doi.org/10.46309/biodicon.2021.908458.
EndNote
Soydam Aydın S, Yücel E (August 1, 2021) Anti-proliferative effect of Cistus laurifolius on human cervical adenocarcinoma (Hep2C), human muscle rhabdomyosarcoma (RD), mouse fibrosarcoma (Wehi 164) cell line. Biological Diversity and Conservation 14 2 236–241.
IEEE
[1]S. Soydam Aydın and E. Yücel, “Anti-proliferative effect of Cistus laurifolius on human cervical adenocarcinoma (Hep2C), human muscle rhabdomyosarcoma (RD), mouse fibrosarcoma (Wehi 164) cell line”, BioDiCon, vol. 14, no. 2, pp. 236–241, Aug. 2021, doi: 10.46309/biodicon.2021.908458.
ISNAD
Soydam Aydın, Semra - Yücel, Ersin. “Anti-Proliferative Effect of Cistus Laurifolius on Human Cervical Adenocarcinoma (Hep2C), Human Muscle Rhabdomyosarcoma (RD), Mouse Fibrosarcoma (Wehi 164) Cell Line”. Biological Diversity and Conservation 14/2 (August 1, 2021): 236-241. https://doi.org/10.46309/biodicon.2021.908458.
JAMA
1.Soydam Aydın S, Yücel E. Anti-proliferative effect of Cistus laurifolius on human cervical adenocarcinoma (Hep2C), human muscle rhabdomyosarcoma (RD), mouse fibrosarcoma (Wehi 164) cell line. BioDiCon. 2021;14:236–241.
MLA
Soydam Aydın, Semra, and Ersin Yücel. “Anti-Proliferative Effect of Cistus Laurifolius on Human Cervical Adenocarcinoma (Hep2C), Human Muscle Rhabdomyosarcoma (RD), Mouse Fibrosarcoma (Wehi 164) Cell Line”. Biological Diversity and Conservation, vol. 14, no. 2, Aug. 2021, pp. 236-41, doi:10.46309/biodicon.2021.908458.
Vancouver
1.Semra Soydam Aydın, Ersin Yücel. Anti-proliferative effect of Cistus laurifolius on human cervical adenocarcinoma (Hep2C), human muscle rhabdomyosarcoma (RD), mouse fibrosarcoma (Wehi 164) cell line. BioDiCon. 2021 Aug. 1;14(2):236-41. doi:10.46309/biodicon.2021.908458

Cited By

❖  Biological Diversity and Conservation (BioDiCon) is an international, peer-reviewed, open-access journal that publishes high-quality scientific research in biodiversity, conservation biology, ecology, life sciences, environmental sciences, and related health sciences.

❖  The journal is committed to maintaining the highest standards of publication ethics and follows the principles and guidelines of the Committee on Publication Ethics (COPE).

❖  All articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) License.

❖  Only manuscripts written in clear and grammatically correct English are accepted.

❖   There is no article processing charge (APC).

❖  Indexes: Additional Web of Science Indexes: Zoological Record, TR Dizin, Medical Reads (RRS), CrossRef;10.46309/biodicon.



❖  Editorial Office

Biological Diversity and Conservation (BioDiCon)

Sazova Mahallesi, Ziraat Caddesi, No.277, F Blok, 26005 Tepebaşı-Eskişehir, Türkiye

Email: info@biodicon.com; biodicon@gmail.com

 Editor-in-Chief: Prof.Dr. Ersin YÜCEL (https://orcid.org/0000-0001-8274-7578)

Website: https://dergipark.org.tr/en/pub/biodicon; http://www.biodicon.com

Publication Start Date 2008 
Publisher: ERSİN YÜCEL (Publisher ID: F2600000047; DergiPark ID: 2067)